HomeCompareBAX vs KMI

BAX vs KMI: Dividend Comparison 2026

BAX yields 2.28% · KMI yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMI wins by $10.0K in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
KMI
KMI
● Live price
3.48%
Share price
$33.65
Annual div
$1.17
5Y div CAGR
12.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.6K
Annual income
$1,607.93
Full KMI calculator →

Portfolio growth — BAX vs KMI

📍 KMI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXKMI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + KMI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
KMI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
KMI
Annual income on $10K today (after 15% tax)
$295.54/yr
After 10yr DRIP, annual income (after tax)
$1,366.74/yr
At 15% tax rate, KMI beats the other by $1,358.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + KMI for your $10,000?

BAX: 50%KMI: 50%
100% KMI50/50100% BAX
Portfolio after 10yr
$25.6K
Annual income
$809.10/yr
Blended yield
3.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMI right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
KMI
Analyst Ratings
16
Buy
17
Hold
1
Sell
Consensus: Hold
Price Target
$34.33
+2.0% upside vs current
Range: $30.00 — $38.00
Altman Z
1.3
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
KMI buys
0
No recent congressional trades found for BAX or KMI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXKMI
Forward yield2.28%3.48%
Annual dividend / share$0.36$1.17
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%12.1%
Portfolio after 10y$20.6K$30.6K
Annual income after 10y$10.26$1,607.93
Total dividends collected$602.00$8.7K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldHold
Analyst price target$19.75$34.33

Year-by-year: BAX vs KMI ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrKMI PortfolioKMI Income/yrGap
1← crossover$10,866$166.33$11,090$389.77$224.00KMI
2$11,750$123.31$12,319$452.85$569.00KMI
3$12,664$90.97$13,708$527.01$1.0KKMI
4$13,617$66.89$15,282$614.40$1.7KKMI
5$14,619$49.07$17,070$717.60$2.5KKMI
6$15,679$35.94$19,104$839.73$3.4KKMI
7$16,802$26.30$21,426$984.61$4.6KKMI
8$17,998$19.23$24,083$1,156.92$6.1KKMI
9$19,272$14.05$27,131$1,362.35$7.9KKMI
10$20,631$10.26$30,638$1,607.93$10.0KKMI

BAX vs KMI: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

KMIEnergy

Kinder Morgan, Inc. operates as an energy infrastructure company in North America. The company operates through four segments: Natural Gas Pipelines, Products Pipelines, Terminals, and CO2. The Natural Gas Pipelines segment owns and operates interstate and intrastate natural gas pipeline, and underground storage systems; natural gas gathering systems and natural gas processing and treating facilities; natural gas liquids fractionation facilities and transportation systems; and liquefied natural gas liquefaction and storage facilities. The Products Pipelines segment owns and operates refined petroleum products, and crude oil and condensate pipelines; and associated product terminals and petroleum pipeline transmix facilities. The Terminals segment owns and/or operates liquids and bulk terminals that stores and handles various commodities, including gasoline, diesel fuel, chemicals, ethanol, metals, and petroleum coke; and owns tankers. The CO2 segment produces, transports, and markets CO2 to recovery and production crude oil from mature oil fields; owns interests in/or operates oil fields and gasoline processing plants; and operates a crude oil pipeline system in West Texas, as well as owns and operates RNG and LNG facilities. It owns and operates approximately 83,000 miles of pipelines and 143 terminals. The company was formerly known as Kinder Morgan Holdco LLC and changed its name to Kinder Morgan, Inc. in February 2011. Kinder Morgan, Inc. was founded in 1936 and is headquartered in Houston, Texas.

Full KMI Calculator →
📬

Get this BAX vs KMI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.